Literature DB >> 1190428

Specific spectrophotometric assays for cathepsin B1.

A S Bajkowski, A Frankfater.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1190428     DOI： 10.1016/0003-2697(75)90685-5

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  3 in total

1.  Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages.

Authors:  G Hoppe; J O'Neil; H F Hoff
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

2.  Human cathepsin B. Application of the substrate N-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide to a study of the inhibition by leupeptin.

Authors:  C G Knight
Journal:  Biochem J       Date:  1980-09-01       Impact factor: 3.857

3.  SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moiety.

Authors:  A Billich; G Fricker; I Müller; P Donatsch; P Ettmayer; H Gstach; P Lehr; P Peichl; D Scholz; B Rosenwirth
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.